Previous 10 | Next 10 |
Gainers: ChemoCentryx (CCXI) +19%. iRhythm Technologies (IRTC) +16%. Jounce Therapeutics (JNCE) +15%. Grifols (GRFS) +9%. Sensus Healthcare (SRTS) +8%. Losers: Joint (JYNT) -46%. Endo International (ENDP) -34%. Guardant Health (GH) -26%. Gain ...
Generic drugmaker Endo International (NASDAQ:ENDP) has lost ~29% in the pre-market so far despite reporting better than expected 1Q 202 financials as the management set the 2Q guidance below the consensus. Revenue for the quarter slipped ~9% YoY to $652.3M, driven by a ~12% YoY...
The following slide deck was published by Endo International plc in conjunction with their 2022 Q1 earnings call. For further details see: Endo International plc 2022 Q1 - Results - Earnings Call Presentation
Endo press release (NASDAQ:ENDP): Q1 Non-GAAP EPS of $0.66 beats by $0.22. Revenue of $652.26M (-9.1% Y/Y) beats by $15.17M. As of March 31, 2022, the Company had approximately $1.4 billion in unrestricted cash; $8.1 billion of debt; and a net debt to adjusted EBITDA ratio of 4.7. ...
ENDO REPORTS FIRST-QUARTER 2022 FINANCIAL RESULTS Canada NewsWire DUBLIN , May 5, 2022 /CNW/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2022 and provided second-quarter 2022 financi...
Endo Aesthetics to Introduce New Clinical Study of Qwo® (collagenase clostridium histolyticum-aaes) at the Annual SCALE Meeting PR Newswire DUBLIN , May 5, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced the upcoming launch...
Palm Beach, FL – May 4, 2022 – FinancialNewsMedia.com News Commentary – Globally, the R&D on breast cancer in all its forms has been steadily growing at a significant pace over the last several years and will continue in the years to come. Breast cancer ...
Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Nevakar Canada NewsWire DUBLIN , May 2, 2022 /CNW/ -- Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited (EVL) acquired six d...
Endo Ventures Limited, a subsidiary of the specialty pharmaceutical company Endo International (NASDAQ:ENDP), has purchased six differentiated, sterile injectable product candidates from Nevakar Injectables, a unit of Nevakar. Announcing the transaction, Nevakar said on Monday that the drugs ...
BRIDGEWATER, N.J., May 02, 2022 (GLOBE NEWSWIRE) -- Nevakar Injectables Inc. (“Nevakar”), a wholly owned subsidiary of Nevakar, Inc., is a biopharmaceutical company developing multiple sterile injectable products for use in the critical and ambulatory care settings. Nevakar an...
News, Short Squeeze, Breakout and More Instantly...
Endo International plc Company Name:
ENDP Stock Symbol:
NASDAQ Market:
Endo International plc Website:
Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Canada NewsWire DUBLIN , Sept. 21, 2023 /CNW/ -- Endo International plc (OTC:...
ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS Canada NewsWire DUBLIN , Aug. 8, 2023 /CNW/ -- Endo International plc (OTC: ENDPQ) today reported financial results for the second-quarter ended June 30, 2023 . SECOND-QUARTER FINANCIAL PERF...
Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe Canada NewsWire The ready-to-use pre-filled syringe combines two well-known, FDA-approved product...